1. Home
  2. COGT vs GRNT Comparison

COGT vs GRNT Comparison

Compare COGT & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • GRNT
  • Stock Information
  • Founded
  • COGT 2014
  • GRNT 2013
  • Country
  • COGT United States
  • GRNT United States
  • Employees
  • COGT 205
  • GRNT N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • GRNT Blank Checks
  • Sector
  • COGT Health Care
  • GRNT Finance
  • Exchange
  • COGT Nasdaq
  • GRNT Nasdaq
  • Market Cap
  • COGT 822.0M
  • GRNT 752.6M
  • IPO Year
  • COGT 2018
  • GRNT N/A
  • Fundamental
  • Price
  • COGT $7.23
  • GRNT $6.35
  • Analyst Decision
  • COGT Buy
  • GRNT Buy
  • Analyst Count
  • COGT 6
  • GRNT 2
  • Target Price
  • COGT $15.20
  • GRNT $7.50
  • AVG Volume (30 Days)
  • COGT 2.1M
  • GRNT 527.6K
  • Earning Date
  • COGT 08-05-2025
  • GRNT 08-07-2025
  • Dividend Yield
  • COGT N/A
  • GRNT 6.92%
  • EPS Growth
  • COGT N/A
  • GRNT N/A
  • EPS
  • COGT N/A
  • GRNT 0.09
  • Revenue
  • COGT N/A
  • GRNT $390,665,000.00
  • Revenue This Year
  • COGT N/A
  • GRNT $30.32
  • Revenue Next Year
  • COGT N/A
  • GRNT $7.79
  • P/E Ratio
  • COGT N/A
  • GRNT $70.52
  • Revenue Growth
  • COGT N/A
  • GRNT 6.26
  • 52 Week Low
  • COGT $3.72
  • GRNT $4.52
  • 52 Week High
  • COGT $12.61
  • GRNT $7.10
  • Technical
  • Relative Strength Index (RSI)
  • COGT 65.40
  • GRNT 67.39
  • Support Level
  • COGT $6.88
  • GRNT $5.99
  • Resistance Level
  • COGT $7.83
  • GRNT $6.22
  • Average True Range (ATR)
  • COGT 0.56
  • GRNT 0.18
  • MACD
  • COGT 0.09
  • GRNT 0.01
  • Stochastic Oscillator
  • COGT 78.17
  • GRNT 90.08

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About GRNT Granite Ridge Resources Inc.

Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.

Share on Social Networks: